Early treatment in migraine: How strong is the current evidence?

Cephalalgia

Volumn 28, Issue SUPPL. 2, 2008, Pages 28-35

  Gendolla, A ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Early; Migraine; Mild; Sensitization; Triptan

Indexed keywords

ALMOTRIPTAN; ELETRIPTAN; FROVATRIPTAN; PLACEBO; RIZATRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ANALGESIA; CLINICAL TRIAL; DISABILITY; DISEASE SEVERITY; DRUG EFFICACY; EARLY INTERVENTION; EVIDENCE BASED MEDICINE; HUMAN; MIGRAINE; PATIENT SATISFACTION; REVIEW;

ANALGESICS; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPERALGESIA; MIGRAINE DISORDERS; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SELF ADMINISTRATION; SEROTONIN AGONISTS; SKIN; TREATMENT OUTCOME; TRIGEMINAL NERVE; TRIGEMINAL NUCLEI; TRYPTAMINES; VASOCONSTRICTOR AGENTS;

EID: 48249088976     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01688.x     Document Type: Review

References (44)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002 346 : 257 70.
2. Diener HC, Limmroth V. Advances in pharmacological treatment of migraine. Expert Opin Investig Drugs 2001 10 : 1831 45.
3. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002 22 : 633 58.
4. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000 60 : 1259 87.
5. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia 2000 20 : 765 86.
6. Ferrari MD. Should we advise patients to treat migraine attacks early? Cephalalgia 2004 24 : 915 17.
7. Dowson AJ, Mathew NT, Pascual J. Review of clinical trials using early acute intervention with oral triptans for migraine management. Int J Clin Pract 2006 60 : 698 706.
8. Pryse-Phillips W, Aube M, Bailey P, Becker WJ, Bellavance A, Gawel M et al. A clinical study of migraine evolution. Headache 2006 46 : 1480 6.
9. Brandes JL. Treatment approaches to maximizing therapeutic response in migraine. Neurology 2003 61 : S21 6.
10. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000 47 : 614 24.
11. Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia 2004 24 (Suppl. 2 2 7.
12. Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache 2006 46 (Suppl. 4 S182 91.
13. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004 55 : 19 26.
14. Taylor FR. Migraine headache: options for acute treatment. Curr Neurol Neurosci Rep 2005 5 : 86 92.
15. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002 42 (Suppl. 1 3 9.
16. Gallagher R. What do patients want from acute migraine treatment? Cephalalgia 2004 24 (Suppl. 2 8 15.
17. Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000 20 : 554 60.
18. Goadsby PJ, Dodick DW, Ferrari MD, McCrory DC, Williams P. TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management. Acta Neurol Scand 2004 110 : 137 43.
19. Santanello NC, Davies G, Allen C, Kramer M, Lipton R. Determinants of migraine-specific quality of life. Cephalalgia 2002 22 : 680 5.
20. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999 39 : S20 6.
21. Weaver MF, Bond DS, Arnold BL, Waterhouse E, Towne A. Aberrant drug-taking behaviors and headache: patient versus physician report. Am J Health Behav 2006 30 : 475 82.
22. Foley KA, Cady R, Martin V, Adelman J, Diamond M, Bell CF et al. Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine. Headache 2005 45 : 538 45.
23. Silberstein SD, Dodick D, Kesslick J. Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size. Headache 2005 45 : 1250 4.
24. Edmeads J. Communication issues in migraine diagnosis. Can J Neurol Sci 2002 29 (Suppl. 2 S8 10.
25. Edmeads J. Understanding the needs of migraine patients. Drugs 2006 66 (Suppl. 3 1 8.
26. Lanteri-Minet M, Allaf B, Mick G. Right triptan use in clinical conditions: results of TEMPO study. Poster P01.124 presented at the American Academy of Neurology 58th Annual Meeting (San Diego 2006.
27. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ et al. Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia 2000 20 : 765 86.
28. D'Amico D, Moschiano F, Bussone G. Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction? Expert Rev Neurother 2006 6 : 1087 97.
29. Brandes JL, Kudrow D, Cady R, Tiseo PJ, Sun W, Sikes CR. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing. Cephalalgia 2005 25 : 735 42.
30. Cady R, Elkind A, Goldstein J, Keywood C. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe. Curr Med Res Opin 2004 20 : 1465 72.
31. Cady R, Martin V, Mauskop A, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F. Efficacy of rizatriptan 10 mg administered early in a migraine attack. Headache 2006 46 : 914 24.
32. Cady RK, Lipton RB, Hall C, Stewart WF, O'Quinn S, Gutterman D. Treatment of mild headache in disabled migraine sufferers: results of spectrum study. Headache 2000 40 : 792 7.
33. Cady RK, Sheftell F, Lipton RB, O'Quinn S, Jones M, Putnam DG et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000 22 : 1035 48.
34. Klapper J, Lucas C, Rosjo O, Charlesworth B. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild. Cephalalgia 2004 24 : 918 24.
35. Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo-controlled trial. Curr Med Res Opin 2005 21 : 381 9.
36. Mathew NT. Early intervention with almotriptan improves sustained pain-free response in acute migraine. Headache 2003 43 : 1075 9.
37. Mathew NT, Kailasam J, Meadors L. Early treatment of migraine with rizatriptan: a placebo-controlled study. Headache 2004 44 : 669 73.
38. Pascual J, Cabarrocas X. Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better. Headache 2002 42 : 28 31.
39. Scholpp J, Schellenberg R, Moeckesch B, Banik N. Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia 2004 24 : 925 33.
40. The International 311C90 Long-term Study Group. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. Headache 1998 38 : 173 83.
41. Winner P, Landy S, Richardson M, Ames M. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Clin Ther 2005 27 : 1785 94.
42. Goadsby PJ, Zanchin G, Geraud G, de Klippel N, Diaz-Insa S, Gobel H et al. Early versus non-early intervention in acute migraine - Act when Mild' (AwM). A double-blind placebo-controlled trial of almotriptan. Cephalalgia 2008 28 : 383 91.
43. Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR et al. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS). Headache 2007 47 : 519 30.
44. Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L et al. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study). Headache 2007 47 : 189 98.